Oberammergau, Germany

Anton Jochner

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 15.6

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Oberammergau, DE (2018 - 2023)
  • Penzberg, DE (2023)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovator Anton Jochner - Pioneering Advances in Biomedicine

Introduction

Anton Jochner, based in Oberammergau, Germany, is a notable inventor with a significant impact in the field of biomedicine. He holds five patents, showcasing his commitment to advancing medical technology and therapeutic interventions. Jochner is known for his groundbreaking work on bispecific anti-CCL2 antibodies.

Latest Patents

Among his most recent innovations are bispecific anti-CCL2 antibodies. These antibodies bind to two different epitopes on human CCL2, paving the way for pharmaceutical compositions designed for the treatment of various health conditions. The implications of this invention are vast, targeting cancers as well as inflammatory, autoimmune, and ophthalmologic diseases.

Career Highlights

Anton Jochner is affiliated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His tenure at Roche has allowed him to dedicate his research efforts towards the development of innovative therapeutic solutions, ensuring his inventions contribute to improving patient outcomes.

Collaborations

Throughout his career, Jochner has collaborated with esteemed colleagues such as Guy Georges and Joerg Moelleken. These collaborations have been instrumental in enhancing the research and development of his patented technologies, fostering a team environment that promotes innovation.

Conclusion

Anton Jochner's contributions to biomedicine through his patents on bispecific anti-CCL2 antibodies highlight the importance of innovation in addressing complex health challenges. His work at Hoffmann-La Roche Inc. continues to inspire advancements that may lead to effective treatments for patients around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…